Clinical Trial Update: The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of psilocybin in cancer patients with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder in Cancer Patients

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Maryland Oncology Hematology, PA | Conditions: Major Depressive Disorder | Phase 2 | Status: UNKNOWN